Side-by-side financials for ELTX and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ELTX | NVS |
|---|---|---|
| Market cap | - | $293.70 B |
| US-listed rank | - | #46 |
| Revenue (latest FY) | $2.30M | - |
| Net income (latest FY) | -$39.57M | - |
| Net margin | -1719.7% | - |
| SEC filings | 360 | 947 |
Full pages: Elicio Therapeutics, Inc. and Novartis AG, or browse the full rankings.